Peter H. Cashin at Uppsala University - Research Interests, Publications & Academic Profile

Peter H. Cashin

Uppsala University

Sweden

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Surgery

50%

Internal Medicine

60%

Colorectal Cancer

70%

Oncology

60%

Gastrointestinal Surgery

60%

Peritoneal Dialysis

60%

Neoadjuvant Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

EFFIPEC trial

Open Date: 2021-01-01

Close Date: 2024-12-01

Grant: Close

Quality of life - HIPEC prospective trial

Open Date: 2018-01-01

Close Date: 2020-01-01

Grant: Close

Circulating Tumour Cells in Peritoneal Surface Malignancies being Treated with Cytoreductive Surgery and HIPEC

Open Date: 2017-01-01

Close Date: 2019-06-01

Grant: Close

National HIPEC study

Open Date: 2016-01-01

Close Date: 2018-06-01

Grant: Close

Circulating Tumour Cells in Peritoneal Surface Malignancies being Treated with Cytoreductive Surgery and HIPEC

Open Date: 2015-11-01

Close Date: 2018-05-01

Articles11

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal Cancer—An Overview of Current Status and Future Perspectives

Article Link

Year:

2024

External validation of prognostic scores and comparison of predictive accuracy for patients with colorectal cancer with peritoneal metastases considered for cytoreductive surgery and intraperitoneal chemotherapy

Article Link

Year:

2023

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases

Article Link

Year:

2023

The impact on postoperative outcomes of intraoperative fluid management strategies during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Article Link

Year:

2023

Perioperative chemotherapy in colorectal cancer with peritoneal metastases: a global propensity score matched study

Article Link

Year:

2023

Surgical treatment of rectovaginal fistula-predictors of outcome and effects on quality of life.

Article Link

Year:

2022

Validating the PSOGI classification of peritoneal disease from non-carcinoid epithelial appendiceal neoplasms in the curative and palliative setting: an observational retrospective study.

Article Link

Year:

2022

An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Article Link

Year:

2022

Morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases with or without early postoperative intraperitoneal chemotherapy: A propensity score matched study.

Article Link

Year:

2022

The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases

Article Link

Year:

2021

Severe pulmonary complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are common and contribute to decreased overall survival.

Article Link

Year:

2021

Collaborators5

Kuno Lehmann

University Hospital of Zurich

SWITZERLAND

Victor Jilbert Verwaal

Lund University

SWEDEN

Mikael Andersson

Karolinska Institutet

SWEDEN

Santiago González-Moreno

ADJUNCT PROFESSOR

The University of Texas MD Anderson Cancer Center

UNITED STATES

David Lawson Morris

Professor of Surgery

AUSTRALIA

How do Indian students reach out?

Meet Kite AI